A detailed history of Korea Investment Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Korea Investment Corp holds 78,500 shares of REGN stock, worth $58.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
78,500
Previous 79,818 1.65%
Holding current value
$58.1 Million
Previous $83.9 Million 1.63%
% of portfolio
0.2%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $1.35 Million - $1.58 Million
-1,318 Reduced 1.65%
78,500 $82.5 Million
Q2 2024

Aug 13, 2024

SELL
$883.2 - $1071.19 $6.2 Million - $7.52 Million
-7,024 Reduced 8.09%
79,818 $83.9 Million
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $12.4 Million - $13.7 Million
-13,759 Reduced 13.68%
86,842 $83.6 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $3.72 Million - $4.24 Million
4,805 Added 5.02%
100,601 $88.4 Million
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $10.1 Million - $12.3 Million
-14,550 Reduced 13.19%
95,796 $78.8 Million
Q2 2023

Aug 11, 2023

BUY
$700.03 - $830.35 $1.88 Million - $2.23 Million
2,687 Added 2.5%
110,346 $79.3 Million
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $3.5 Million - $4.26 Million
-5,146 Reduced 4.56%
107,659 $88.5 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $4.48 Million - $4.87 Million
-6,348 Reduced 5.33%
112,805 $81.4 Million
Q3 2022

Nov 10, 2022

BUY
$573.97 - $724.32 $5.99 Million - $7.56 Million
10,443 Added 9.61%
119,153 $82.1 Million
Q2 2022

Aug 12, 2022

BUY
$548.35 - $738.84 $3.49 Million - $4.71 Million
6,369 Added 6.22%
108,710 $64.3 Million
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $27.9 Million - $32.7 Million
46,828 Added 84.36%
102,341 $71.5 Million
Q4 2021

Feb 09, 2022

SELL
$543.48 - $670.97 $16.6 Million - $20.5 Million
-30,549 Reduced 35.5%
55,513 $35.1 Million
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $13.8 Million - $16.4 Million
24,016 Added 38.71%
86,062 $52.1 Million
Q2 2021

Aug 12, 2021

SELL
$472.8 - $558.54 $529,536 - $625,564
-1,120 Reduced 1.77%
62,046 $34.7 Million
Q1 2021

May 13, 2021

SELL
$446.73 - $548.2 $2.07 Million - $2.54 Million
-4,634 Reduced 6.83%
63,166 $29.9 Million
Q4 2020

Feb 10, 2021

BUY
$478.3 - $607.98 $13.1 Million - $16.7 Million
27,400 Added 67.82%
67,800 $32.8 Million
Q3 2020

Nov 12, 2020

BUY
$544.75 - $658.21 $4.47 Million - $5.4 Million
8,200 Added 25.47%
40,400 $22.6 Million
Q2 2020

Aug 12, 2020

SELL
$493.32 - $643.92 $14.6 Million - $19 Million
-29,500 Reduced 47.81%
32,200 $20.1 Million
Q1 2020

May 14, 2020

BUY
$336.18 - $494.43 $1.61 Million - $2.37 Million
4,800 Added 8.44%
61,700 $30.1 Million
Q4 2019

Feb 11, 2020

BUY
$274.13 - $376.51 $4.22 Million - $5.8 Million
15,400 Added 37.11%
56,900 $21.4 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $1.56 Million - $1.81 Million
5,700 Added 15.92%
41,500 $11.5 Million
Q2 2019

Aug 12, 2019

SELL
$299.6 - $414.82 $1.71 Million - $2.36 Million
-5,700 Reduced 13.73%
35,800 $11.2 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $2.34 Million - $2.76 Million
6,288 Added 17.86%
41,500 $17 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $3.85 Million - $4.63 Million
11,479 Added 48.37%
35,212 $13.2 Million
Q3 2018

Nov 13, 2018

SELL
$351.14 - $408.51 $6.71 Million - $7.81 Million
-19,109 Reduced 44.6%
23,733 $9.59 Million
Q2 2018

Aug 13, 2018

SELL
$284.6 - $344.99 $529,356 - $641,681
-1,860 Reduced 4.16%
42,842 $0
Q1 2018

May 09, 2018

BUY
$315.82 - $393.78 $4.18 Million - $5.21 Million
13,221 Added 42.0%
44,702 $15.4 Million
Q4 2017

Feb 12, 2018

BUY
$358.63 - $469.95 $4.27 Million - $5.59 Million
11,900 Added 60.77%
31,481 $11.8 Million
Q3 2017

Oct 25, 2017

BUY
$431.38 - $504.0 $8.45 Million - $9.87 Million
19,581
19,581 $8.76 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.